Literature DB >> 9515820

Differential regulation of cyclin-dependent kinase inhibitors in monolayer and spheroid cultures of tumorigenic and nontumorigenic fibroblasts.

K E LaRue1, E M Bradbury, J P Freyer.   

Abstract

The Ras proto-oncogene has been implicated in the in vivo development of tumors and in the in vitro transformation of cultured cell lines. In both of these conditions, Ras-mediated disruption of cell cycle-regulatory mechanisms leads to unregulated cellular proliferation, although the exact mechanisms by which Ras accomplishes this are not clear. Using as a model the M1 and MR1 rat fibroblast cell lines, which differ in the expression of a regulated Ras (M1 cells) versus a constitutively active Ras (MR1 cells), we examined the role of Ras in the control of cellular proliferation in two-dimensional (monolayer) and three-dimensional (spheroid) cell cultures. These cell lines are very similar in their monolayer growth characteristics, but M1 cells will arrest their cell cycle progression in aggregate culture, whereas MR1 cells proliferate normally as small spheroids. We report here that G1-phase arrest in plateau-phase monolayer cultures of both M1 and MR1 cells correlates with up-regulated expression of the cyclin-dependent kinase (CDK) inhibitor p18INK4c. Enhanced p18INK4c expression was also observed in G1-arrested M1 cells cultured as multicellular spheroids but was not induced in small proliferating MR1 multicellular spheroids. The kinetics of G1 arrest in M1 cells after inoculation into aggregate culture correlated well with the induction of p18INK4c expression. Conversely, resumption of proliferation in monolayer culture of arrested M1 cells isolated from spheroids coincided with the loss of expression of p18INK4c. After extended culture, cells in the inner region of MR1 spheroids arrested in the G1 phase without any up-regulation of p18INK4c expression. In this case, the CDK inhibitor p21(Cip1/Waf1) was selectively induced in the inner regions of large MR1 spheroids, concomitant with a decrease in cyclin and CDK expression. Thus, Ras-dependent regulation of p18INK4c expression seems to control the ability of rat embryo fibroblasts to proliferate as small multicellular aggregates, whereas p21(Cip1/Waf1) expression seems to regulate the G1-phase arrest induced by the stressful microenvironment found within the inner region of large spheroids.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9515820

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Differential expression of CD44(S) and variant isoforms v3, v10 in three-dimensional cultures of mouse melanoma cell lines.

Authors:  Anjali Shiras; Arti Bhosale; Anjali Patekar; Varsha Shepal; Padma Shastry
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

2.  A multiscale model for avascular tumor growth.

Authors:  Yi Jiang; Jelena Pjesivac-Grbovic; Charles Cantrell; James P Freyer
Journal:  Biophys J       Date:  2005-09-30       Impact factor: 4.033

3.  Mouse fibroblast cell adhesion studied by neutron reflectometry.

Authors:  Hillary L Smith; Joseph Hickey; Michael S Jablin; Antoinette Trujillo; James P Freyer; Jaroslaw Majewski
Journal:  Biophys J       Date:  2010-03-03       Impact factor: 4.033

4.  PTTG2 silencing results in induction of epithelial-to-mesenchymal transition and apoptosis.

Authors:  C Méndez-Vidal; M del Mar Gámez-Del Estal; M A Moreno-Mateos; A G Espina-Zambrano; B Torres; J A Pintor-Toro
Journal:  Cell Death Dis       Date:  2013-03-07       Impact factor: 8.469

5.  Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids.

Authors:  Sylvain L'Espérance; Magdalena Bachvarova; Bernard Tetu; Anne-Marie Mes-Masson; Dimcho Bachvarov
Journal:  BMC Genomics       Date:  2008-02-26       Impact factor: 3.969

6.  Differential expression and role of p21cip/waf1 and p27kip1 in TNF-alpha-induced inhibition of proliferation in human glioma cells.

Authors:  Pabbisetty Sudheer Kumar; Anjali Shiras; Gowry Das; Jayashree C Jagtap; Vandna Prasad; Padma Shastry
Journal:  Mol Cancer       Date:  2007-06-12       Impact factor: 27.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.